• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

JTT-851

(CAS: )

Suppliers of JTT-851

Company Name Email Tel Country
AMEDCHEM [email protected] +862168061059 CHINA

Fax: Purity: Brand:

Inquiry Online

Salutation: *Country:
*Customer: *Company Name:
*Email: *Request quantity:
Remarks:
 

Notice: Your contact information will be sent to selected suppliers.

* Required Fields.

Background Information of JTT-851

JTT-851 is a GPR40 partial agonist. GPR40, also known as FFAR1, belongs to the class A family of G-protein coupled receptors, and is expressed predominantly in pancreatic β cells and enteroendocrine cells.GPR40 partial agonism is a promising new mechanism for the treatment of type 2 diabetes mellitus with clinical proof of concept. 

Solubility of JTT-851

Solubility Sources

Storage Condition of JTT-851

Storage Condition Sources

MSDS Information

MSDS Sources

Quality Control and Spectral Data

QC Reports Sources

Mechanism and Indications

Signaling Pathways GPCR/G Protein
Target GPR40
Research Area Metabolic Disease
Indications

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase

Chemical Information

M.Wt Formula CAS No. Synonyms
352.47 C23H28O3

Structure Information of JTT-851

Smiles C1CCC2(CC(COC3C=CC([[email protected]](C(O)=O)C#CC)=CC=3)=CCC2)CC1 |&1:12|
InChI InChI=1S/C23H28O3/c1-2-7-21(22(24)25)19-9-11-20(12-10-19)26-17-18-8-6-15-23(16-18)13-4-3-5-14-23/h8-12,21H,3-6,13-17H2,1H3,(H,24,25)/t21-/m1/s1

Related Products

Other Form Products of JTT-851

Name CAS Formula Suppliers

Recommended Products in Same Target

Name CAS Formula Suppliers
AMG 837 (calcium hydrate) 1259389-38-2 C26H22F3O4- 9
AMG 837 (sodium salt) 865231-45-4 C26H20F3NaO3 6
GPR40 Activator 1 1309435-60-6 C31H31NO3S 6
AMG 837 865231-46-5 C26H21F3O3 12
TUG-770 1402601-82-4 C19H14FNO2 13
GW9508 885101-89-3 C22H21NO3 22
TAK-875 1000413-72-8 C29H32O7S 16
GW-1100 306974-70-9 C27H25FN4O4S 9
GPR40 Activator 2 1312787-30-6 C28H29NO6S2 6
DC260126 346692-04-4 C32H31N5O 7
M-I C19H22O5S 0
T-1676427 1000414-39-0 C29H32O8S 0
Astellas C27H30N4O4 0
MK-2305 905723-46-8 C19H13ClF3NO4S 0
Mochida 1469495-84-8 C30H35NO6S 0
BMS-986118 1610562-74-7 C25H28ClF3N4O4 2
AM-6226 C32H36F2O4 0
GPR40 agonist 1 1312788-44-5 C24H20O3 0
GPR40 agonist 2 C25H22O3 0
GPR40 agonist 3 C23H18O3 0

Recommended Products in the Same Indication

Name CAS Formula Suppliers

Chemical and Physical Properties

Appearance: Melting point:
Boiling point: Flash Point:
Water Solubility: Solubility:
Density: Merck:
BRN: Refractive Index:
Vapour: EINECS:
Optical Rotation: alpha:

Reference

[1].Huang H, et al. Discovery of novel benzo[b]thiophene tetrazoles as non-carboxylate GPR40 agonists. Bioorg Med Chem Lett. 2017 Dec 12. pii: S0960-894X(17)31182-4.
GPR40 partial agonism is a promising new mechanism for the treatment of type 2 diabetes mellitus with clinical proof of concept. Most of the GPR40 agonists in the literature have a carboxylic acid functional group, which may pose a risk for idiosyncratic drug toxicity. A novel series of GPR40 agonists containing a tetrazole as a carboxylic acid bioisostere was identified. This series of compounds features a benzo[b]thiophene as the center ring, which is prone to oxidation during phase 1 metabolism. Following SAR optimization targeting GPR40 agonist activity and intrinsic clearance in microsomes (human and rat), potent and metabolically stable compounds were selected for in vivo evaluation. The compounds are efficacious at lowering blood glucose in a SD rat oGTT model.

Tags: buy JTT-851 | JTT-851 IC50 | JTT-851 price | JTT-851 cost | JTT-851 solubility | JTT-851 purchase | JTT-851 manufacturer | JTT-851 research buy | JTT-851 order | JTT-851 MSDS | JTT-851 chemical structure | JTT-851 Storage condition | JTT-851 molecular weight | JTT-851 mw | JTT-851 datasheet | JTT-851 supplier | JTT-851 cell line | JTT-851 NMR | JTT-851 MS | JTT-851 IR | JTT-851 solubility | JTT-851 Safe information | JTT-851 Qc and Spectral Information | JTT-851 Clinical Information | JTT-851 Clinical Trial | JTT-851 Route of Synthesis | JTT-851 storage condition | JTT-851 diseases and conditions | JTT-851 flash point | JTT-851 boiling point | JTT-851 melting point | JTT-851 storage condition | JTT-851 brand